SummitIn person

2nd Obesity & Weight Loss Drug Development Summit Europe

Name: 2nd Obesity & Weight Loss Drug Development Summit Europe
Start: 2026-10-28
End: 2026-10-29
Location: Hyperion Hotel München

Hosted by Hanson Wade

28 – 29 October 2026
Add to calendar
Apple / Outlook (.ics)Google Calendar
Welcome to kongre.net
Events Categories News
Hyperion Hotel München, Munich, Germany
Health SciencesPharmacy & Pharmaceutical SciencesMedical & Health SciencesClinical Medicine

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Official website

Programme

Published

26 sessions across 2 days

20 speakers

Browse programme

Call for Papers

Submissions are handled by the organiser

View submission details

Registration

Registration is handled by the organiser

Go to registration

Key facts

2nd Obesity & Weight Loss Drug Development Summit Europe is a summit held 28 – 29 October 2026 in Hyperion Hotel München, Munich, Germany, organised by Hanson Wade.

Dates:: 28 – 29 October 2026
Format:: In person
Venue:: Hyperion Hotel München, Munich, Germany
Subjects:: Pharmacy & Pharmaceutical Sciences, Clinical Medicine
Organiser:: Hanson Wade
Official website:: obesity-drug-development-europe.com

The 2nd Obesity & Weight Loss Drug Development Summit Europe is an industry-centred forum exploring new mechanisms of action, combination therapies, and tolerability improvements to define the next generation of obesity and weight loss therapeutics.

Conference theme

Defining the Second Wave of Competitive & Efficacious Weight Loss Therapeutics

Objectives

To engage with leading innovators and stakeholders to advance the next wave of obesity therapeutics beyond first-generation GLP-1s, uncover innovative targets, emerging combinations, and patient phenotyping approaches.